Back

Sudarshan Pharma Industries Ltd

IPO Details · GMP · Subscription · Financials

✅ Listed BSE SME SME Live Chart
Issue Price
₹73
Per Share
GMP
NIL
Grey Market
Est. Listing
₹73
Expected Price
Min. Application
₹233,600
2 lots × 1600 shares
IPO Issue Details
Issue Price / Price Band₹73 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,600 Shares per Lot
Total Issue Size68,62,400 shares (aggregating up to ₹50.10 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenThu, 09 Mar 2023
Subscription CloseTue, 14 Mar 2023
Anchor AllotmentWed, 08 Mar 2023
Basis of AllotmentFri, 17 Mar 2023
Initiation of RefundsMon, 20 Mar 2023
Credit of Shares to DematTue, 21 Mar 2023
Listing DateWed, 22 Mar 2023
UPI Mandate Deadline2023-03-14
Application & Investment Details
Retail — Min (1 Lots)₹1,16,800 — 1,600 shares
Retail — Max (13 Lots)₹1,518,400 (13 Lots)
HNI — Min (2 Lots)₹2,33,600 — 3,200 shares
P/E Ratio (Pre-IPO)24.33x
Net Offer to Public65,18,400 shares (aggregating up to ₹47.58 Cr)
Reserved for Market Maker3,44,000 shares (aggregating up to ₹2.51 Cr)
Pre-IPO Promoter Holding95,46,998 shares
Post-IPO Promoter Holding1,29,86,998 shares
About Sudarshan Pharma Industries Ltd

Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.The competitive strengths of the company are:1. Customer-centric and order-driven business model2. Wide range of product offerings3. Contract manufacturing facility arrangements4. Strong distribution, marketing, and sales network5. Diversified business operations

Objects of the Issue

Sudarshan Pharma Industries Ltd proposes to utilise the net proceeds from the Issue for the following objects:

1
To set up a dedicated manufacturing facility for Pharmaceutical Business
12.50
2
Distribution and Warehousing Centre‘s & Purchase of Corporate Office
4.50
3
Additional Working Capital
5.25
4
General Corporate Expenses
2.80
Shareholding & Lock-in
Pre-IPO Promoter Holding 95,46,998 shares
Post-IPO Promoter Holding 1,29,86,998 shares
Check AllotmentCheck Status →
Sudarshan Pharma Industries Ltd — Live Price LIVE
₹73.00
INR · BSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Sudarshan Pharma Industries Ltd is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹73.00 Live Price
Quick Facts
GMP Signal ⚪ No GMP
StatusListed
Issue Price₹73
GMPNIL
Est. Listing₹73
Lot Size1,600 shares
Min Amount₹233,600
Listing Date22 Mar 2023
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹73
Listing Date22 Mar 2023
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
Market Maker 344,000 ₹2.51 Cr
TOTAL 6,862,400 100.00% ₹50.10 Cr
* Based on ₹73.00 (upper price band)
Lot Size & Investment Details
Lot Size
1,600
Shares
Issue Price
₹73.00
Per Share
Min Investment
₹116,800
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 1,600 ₹116,800
Retail (Max) 13 20,800 ₹1,518,400
sNII (Min) 14 22,400 ₹1,635,200
bNII (Min) 68 108,800 ₹7,942,400
Company Financials — Restated Consolidated (Amount in ₹ Lakhs)
Particulars30-Sep-2231-Mar-2231-Mar-21
Revenue from Operations 19589.87 35755.89 19372.82
EBITDA N/A N/A N/A
Profit After Tax (PAT) 360.70 530.37 267.12
Net Worth 5108.79 2977.53 2250.74
Total Assets 16402.22 13752.18 9926.02
Reserves & Surplus 3996.89 2002.63 1296.05
Total Borrowings 4940.50 3059.24 2977.09
Key Ratios & Valuation
Issue Price ₹73
Face Value ₹10 Per Share
P/BV N/A
RoE N/A
RoCE N/A
RoNW N/A
PAT Margin (%) N/A
EBITDA Margin (%) N/A
Debt / Equity N/A
Company Details
Company
Sudarshan Pharma Industries Ltd
Exchange
BSE SME
IPO Type
SME IPO
Issue Type
Bookbuilding IPO
Face Value
₹10 Per Share
Script Code
N/A
Address
301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai - 400092 Mumbai, Maharashtra
Book Running Lead Managers
Gretex Corporate Services Ltd
Book Running Lead Manager (BRLM)